Infectious disease · Phase II

Top sponsors

• BRIGHT MINDS BIOSCIENCES 27 programs
• United Therapeutics Europe 23 programs
• Chinese Academy of 16 programs
• Takeda 16 programs
• Vir Biotechnology 15 programs
• Vertex Pharmaceuticals (Australia) 12 programs
• Sinovac Research and 11 programs
• GSK Glaxo Smith 10 programs
• ENANTA PHARMACEUTICALS 8 programs
• Arrowhead Pharmaceuticals Ireland 7 programs
• Regeneron UK 7 programs
• Anaxis Pharma 6 programs

1. -

   The George Institute

   Cytomegalovirus infection post allogeneic allogeneic HLA-identical familial PHT

   phase 2 · small molecule · active

   1 trial →

2. 1% tenofovir gel

   BRIGHT MINDS BIOSCIENCES INC.

   HIV Infections

   phase 2 · small molecule · completed

   1 trial →

3. 1.6

   Disc Medicine

   HIV-1

   phase 2 · small molecule · active

   1 trial →

4. 100U EV71 vaccine with adjuvant

   Sinovac Research and Development Co.,

   Infection, Viral, Enterovirus

   phase 2 · mab · completed

   1 trial →

5. 16mg，KB

   Xiyuan Hospital of China Academy of Chinese Medical Sciences

   Sepsis

   phase 2 · small molecule · active

   1 trial →

6. 2026-525211-14-00

   Disc Medicine

   HIV-1

   phase 2 · small molecule · active

   1 trial →

7. 206882

   GlaxoSmithKline

   Chronic Hepatitis B

   phase 2 · other · active

   1 trial →

8. 212580

   ViiV Healthcare Pty Ltd

   HIV Infections

   phase 2 · small molecule · active

   1 trial →

9. 217043

   GlaxoSmithKline

   Infections, Meningococcal

   phase 2 · small molecule · active

   1 trial →

10. 218307

    ViiV Healthcare Pty Ltd

    HIV Infections

    phase 2 · small molecule · active

    1 trial →

11. 219231

    GlaxoSmithKline

    Hepatitis B

    phase 2 · small molecule · active

    1 trial →

12. 222638

    ViiV Healthcare Pty Ltd

    HIV Infections

    phase 2 · small molecule · active

    1 trial →

13. 224083

    GlaxoSmithKline

    Respiratory Syncytial Virus Infections

    phase 2 · small molecule · active

    1 trial →

14. 400 U EV71 vaccine with adjuvant

    Sinovac Research and Development Co.,

    Infection, Viral, Enterovirus

    phase 2 · mab · terminated

    1 trial →

15. 413ABM

    BRIGHT MINDS BIOSCIENCES INC.

    MALARIA

    phase 2 · other · completed

    1 trial →

16. 5 mg/kg CM-101

    Chemomab Therapeutics

    Nonalcoholic Steatohepatitis

    phase 2 · mab · completed

    1 trial →

17. 5% Nu-3 gel

    Lakewood-Amedex Biotherapeutics

    Diabetic Foot Infection

    phase 2 · small molecule · active

    1 trial →

18. 851B

    Takeda

    Papillomavirus Infections

    phase 2 · small molecule · terminated

    2 trials →

19. AB-729

    Arbutus Biopharma Corp

    Chronic Hepatitis b

    phase 2 · small molecule · completed

    1 trial →

20. AB-729-203

    Arbutus Biopharma Corp

    Chronic HBV Infection

    phase 2 · small molecule · active

    1 trial →

21. ABI-H0731

    ASSEMBLY BIOSCIENCES, INC.

    Chronic Hepatitis B

    phase 2 · small molecule · terminated

    6 trials →

22. ACE393

    Fulcrum Therapeutics

    Campylobacter Infection

    phase 2 · mab · active

    1 trial →

23. ACT-20-MSC

    Aspire Biopharma Holdings

    COVID-19 Pneumonia

    phase 2 · mab · active

    1 trial →

24. ADX-629

    Aldeyra Therapeutics

    Covid19

    phase 2 · small molecule · completed

    1 trial →

25. ADX-629

    Aldeyra Therapeutics

    Alcohol Hepatitis

    phase 2 · small molecule · completed

    1 trial →

26. AK0529

    Shanghai University of Traditional Chinese Medicine

    RESPIRATORY SYNCYTIAL VIRUS INFECTIONS

    phase 2 · small molecule · completed

    1 trial →

27. AL-335

    Janssen Cilag International NV

    Hepatitis C, Chronic

    phase 2 · small molecule · completed

    1 trial →

28. ALG-000184

    Aligos Therapeutics

    Chronic Hepatitis B Infection

    phase 2 · small molecule · active

    1 trial →

29. ALG-000184-202

    Aligos Therapeutics

    Chronic Hepatitis B Virus Infection

    phase 2 · small molecule · active

    1 trial →

30. ALN-HSD

    Regeneron UK Limited

    Metabolic Dysfunction-Associated SteatoHepatitis (MASH)

    phase 2 · small molecule · active

    1 trial →

31. ALN-RSV01

    Alnylam Netherlands B.V.

    Respiratory Syncytial Virus Infections

    phase 2 · small molecule · completed

    3 trials →

32. ANAKINRA

    AXIM BIOTECHNOLOGIES, INC.

    Hyperinflammation, Sepsis

    phase 2 · small molecule · active

    1 trial →

33. APHP210084

    Pari Pharma GmbH

    first suspected infection with Mycobacterium tuberculosis in the lungs

    phase 2 · small molecule · active

    1 trial →

34. APHP230848

    Pari Pharma GmbH

    Non-infectious active cryoglobulinemia vasculitis who are either refractory or intolerant to Rituximab

    phase 2 · small molecule · active

    1 trial →

35. APHP240923

    Pari Pharma GmbH

    Sepsis

    phase 2 · small molecule · active

    1 trial →

36. APL-9

    Apellis Europe B.V.

    COVID

    phase 2 · small molecule · completed

    1 trial →

37. ARB-001467

    Arbutus Biopharma Corp

    Hepatitis B, Chronic

    phase 2 · small molecule · completed

    1 trial →

38. ARC-520

    Arrowhead Pharmaceuticals Ireland Limited

    Hepatitis B, Chronic

    phase 2 · small molecule · terminated

    1 trial →

39. ARC-520

    Arrowhead Pharmaceuticals Ireland Limited

    Hepatitis B

    phase 2 · small molecule · terminated

    2 trials →

40. ARC-520

    Arrowhead Pharmaceuticals Ireland Limited

    Chronic Hepatitis B

    phase 2 · small molecule · terminated

    1 trial →

41. ARC-520 Injection

    Arrowhead Pharmaceuticals Ireland Limited

    Hepatitis B

    phase 2 · small molecule · terminated

    2 trials →

42. ARC-520 Injection

    Arrowhead Pharmaceuticals Ireland Limited

    Chronic Hepatitis B

    phase 2 · small molecule · terminated

    1 trial →

43. ARCT-021 single dose priming

    Arcturus Therapeutics Holdings

    Covid19

    phase 2 · mab · terminated

    1 trial →

44. ARCT-165

    Arcturus Therapeutics Holdings

    COVID-19

    phase 2 · mab · completed

    1 trial →

45. ARO-HBV

    Arrowhead Pharmaceuticals Ireland Limited

    Hepatitis B

    phase 2 · small molecule · completed

    1 trial →

46. ARO-HSD Injection

    Arrowhead Pharmaceuticals Ireland Limited

    Non-alcoholic Steatohepatitis

    phase 2 · small molecule · completed

    1 trial →

47. ASC22

    The First People's Hospital of Lianyungang

    Chronic Hepatitis b

    phase 2 · small molecule · completed

    1 trial →

48. AT-527

    Atea Pharmaceuticals

    Hepatitis C

    phase 2 · small molecule · completed

    1 trial →

Frequently asked questions